ArticleNeoplasia (New York, N.Y.)2026

Targeting the ANXA2-CD63-exosomal PD-L1 axis in hepatocellular carcinoma: A novel mechanism of immune evasion and its implications for precision immunotherapy.

Jian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.